维普期刊资源整合服务平台（V6.5）

1648篇 您的检索式：期刊名="Gynecologic Oncology"

选中清除导出查看参考文献查看引证文献引用追踪共83页首页上一页第1页下一页末页 /83 跳转

	题名	作者	年代	出处	被引量
1	Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence显示文摘	Laura J. Havrilesky Clark M. Whitehead Jennifer M. Rubatt Robert L. Cheek John Groelke Qin He Douglas P. Malinowski Timothy J. Fischer Andrew Berchuck	2008	Gynecologic Oncology2008，，3：	7
2	The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass显示文摘	Richard G. Moore Amy K. Brown M. Craig Miller Steven Skates W. Jeffrey Allard Thorsten Verch Margaret Steinhoff Geralyn Messerlian Paul DiSilvestro C.O. Granai Robert C. Bast	2007	Gynecologic Oncology2007，，2：	7
3	Current state of biomarker development for clinical application in epithelial ovarian cancer显示文摘	Richard G. Moore Shannon MacLaughlan Robert C. Bast	2009	Gynecologic Oncology2009，，2：	4
4	Adenocarcinoma: A unique cervical cancer显示文摘	Lilian T. Gien Marie-Claude Beauchemin Gillian Thomas	2009	Gynecologic Oncology2009，，1：	3
5	Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus显示文摘	Richard G. Moore Amy K. Brown M. Craig Miller Donna Badgwell Zhen Lu W. Jeffrey Allard C.O. Granai Robert C. Bast Karen Lu	2008	Gynecologic Oncology2008，，2：	3
6	MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer显示文摘	Douglas D. Taylor Cicek Gercel-Taylor	2008	Gynecologic Oncology2008，，1：	3
7	A prospective phase II study of topotecan (Hycamtin?) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer显示文摘	N. Manci C. Marchetti C. Di Tucci M. Giorgini F. Esposito I. Palaia A. Musella G. Perniola A. Carrone P. Benedetti Panici	2011	Gynecologic Oncology2011，，2：	3
8	A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass显示文摘	Richard G. Moore D. Scott McMeekin Amy K. Brown Paul DiSilvestro M. Craig Miller W. Jeffrey Allard Walter Gajewski Robert Kurman Robert C. Bast Steven J. Skates	2008	Gynecologic Oncology2008，，1：	3
9	The association between metabolic abnormality and endometrial cancer: A large case-control study in China显示文摘	Yan Zhang Zhiwei Liu Xinchun Yu Xiaofei Zhang Shiming Lü Xiaoduan Chen Bingjian Lü	2010	Gynecologic Oncology2010，，1：	3
10	Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors显示文摘	Yoon-La Choi Seok-Hyung Kim Young Kee Shin Yun-Chul Hong Sun-Joo Lee So Young Kang Geunghwan Ahn	2005	Gynecologic Oncology2005，，2：	2
11	A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy显示文摘	Robert M. Wenham James Lapolla Hui-Yi Lin Sachin M. Apte Johnathan M. Lancaster Patricia L. Judson Jesus Gonzalez-Bosquet Amber Herschberger Laura J. Havrilesky Angeles Alvarez Secord	2013	Gynecologic Oncology2013，，1：	2
12	Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test显示文摘	Thomas C. Wright Mark H. Stoler Catherine M. Behrens Abha Sharma Guili Zhang Teresa L. Wright	2015	Gynecologic Oncology2015，，2：	2
13	Expression of Bcl-x L in ovarian carcinoma is associated with chemoresistance and recurrent disease显示文摘	Jennifer Williams Peter C. Lucas Kent A. Griffith Milheon Choi Sarah Fogoros Yuan Yuan Hu J. Rebecca Liu	2004	Gynecologic Oncology2004，，2：	2
14	Nerve-sparing radical hysterectomy: a surgical technique for preserving the autonomic hypogastric nerve显示文摘	Francesco Raspagliesi Antonino Ditto Rosanna Fontanelli Eugenio Solima Francesco Hanozet Flavia Zanaboni Shigeki Kusamura	2004	Gynecologic Oncology2004，，2：	2
15	Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma显示文摘	Guo-Fen Yang Dan Xie Ji-Hong Liu Jun-Hang Luo Li-Juan Li Wen-Feng Hua Hong-Mei Wu Hsiang-Fu Kung Yi-Xin Zeng Xin-Yuan Guan	2008	Gynecologic Oncology2008，，2：	2
16	The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC)显示文摘	Sonia Dutta Feng-qiang Wang Hai-shan Wu Thayer J. Mukherjee David A. Fishman	2011	Gynecologic Oncology2011，，1：	2
17	More than a biomarker: CA125 may contribute to ovarian cancer pathogenesis显示文摘	Robert C. Bast David R. Spriggs	2011	Gynecologic Oncology2011，，：	2
18	Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer显示文摘	Jeong-Yeol Park Seung Mi Lee Chong Woo Yoo Sokbom Kang Sang-Yoon Park Sang-Soo Seo	2007	Gynecologic Oncology2007，，1：	2
19	Association between endometriosis and cancer: A comprehensive review and a critical analysis of clinical and epidemiological evidence显示文摘	Edgardo Somigliana Paola Vigano’ Fabio Parazzini Sandra Stoppelli Erika Giambattista Paolo Vercellini	2005	Gynecologic Oncology2005，，2：	2
20	No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting显示文摘	Francis Jacob Mara Meier Rosmarie Caduff Darlene Goldstein Tatiana Pochechueva Neville Hacker Daniel Fink Viola Heinzelmann-Schwarz	2011	Gynecologic Oncology2011，，3：	2

返回顶部每页显示：

共83页首页上一页第1页下一页末页 /83 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示